Pioglitazone influence of triglyceride accumulation in the myocardium in diabetes

Trial Profile

Pioglitazone influence of triglyceride accumulation in the myocardium in diabetes

Completed
Phase of Trial: Phase II

Latest Information Update: 19 Nov 2014

At a glance

  • Drugs Pioglitazone (Primary) ; Metformin
  • Indications Type 2 diabetes mellitus
  • Focus Pharmacodynamics
  • Acronyms PIRAMID
  • Most Recent Events

    • 16 Sep 2011 Results of an analysis that focused on plasma omentin levels presented at the 47th Annual Meeting of the European Association for the Study of Diabetes.
    • 29 Jun 2010 Effects of pioglitazone on plasma cholesteryl ester transfer protein (CETP) mass have been presented at the 70th Annual Scientific Sessions of the American Diabetes Association.
    • 01 Jan 2010 Effects on pericardial fat volume have been published in the Journal of Clinical Endocrinology and Metabolism.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top